Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Altmueller, Janine Dr.med. (1) Birchmeier, Walter Prof. Dr. (1) Blankenstein, Thomas Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Dörr, Jan Rafael (7) Fielitz, Jens Dr. (1) Fritsche, Raphaela Dr. (1) Henssen, Anton Prof. Dr. med. (1) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Janz, Martin Dr. (1) Kammertöns, Thomas Dr. (1) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kirchner, Marieluise Dr. (1) Kirwan, Jennifer Dr. (1) Kunz, Severine Dr. (2) Landthaler, Markus Prof. Dr. (1) Mathas, Stephan Dr. (3) Mertins, Philipp Dr. (1) Na, Il-Kang Dr. (3) Rusu, Mara-Camelia Dr. (1) Scheidereit, Claus Prof. Dr. (2) Schmidt-Ullrich, Ruth Dr. (1) Schreiber, Adrian PD Dr. med. (1) Specker, Edgar Dr. (1) Stein, Ulrike Prof. Dr. (2) Uyar, Bora Dr. (1) von Kries, Jens Peter Dr. (1) Wolf, Susanne Dr. (1) Wyler, Emanuel Dr. (1) (-) Schmitt, Clemens Prof. Dr. (89) 2002 (1) 2003 (3) 2004 (2) 2005 (2) 2006 (2) 2007 (4) 2010 (3) 2011 (3) 2012 (3) 2013 (2) 2014 (1) 2016 (8) 2017 (6) 2018 (6) 2019 (7) 2020 (7) 2021 (11) 2022 (9) 2023 (6) 2024 (3) AG Müller/Dechend (ECRC) (2) AG Schreiber [ECRC] (3) Anchored Signalling (13) Animal Phenotyping (3) Bioinformatics and Omics Data Science (2) Biology of Malignant Lymphomas (3) (-) Cancer Genetics and Cellular Stress Responses (89) Cardiac MRI (1) Cellular Neurosciences (6) Clinical Research Unit (1) Electron Microscopy (2) Epigenetic Modifications in Neuroblastoma (2) Epigenetic Regulation and Chromatin Architecture (4) Experimental Ultrahigh-Field MR (24) Genetics and Genomics of Cardiovascular Diseases (3) Genomics (2) Host-microbiome factors in cardiovascular disease (2) Hypertension-caused End-Organ Damage (2) Hypertension-Mediated End-Organ Damage (2) Immune Dysregulations in Oncology (3) Integrative Vascular Biology (1) Magnetic Resonance (24) Mechanism-based Cancer Therapies (2) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (1) Molecular Biology of Peptide Hormones (3) Molecular Cardiovascular Research (1) Molecular Genetics of Chronic Inflammation and Allergic Disease (1) Molecular Immunology and Gene Therapy (4) Molecular Pathways in Cortical Development (1) Molecular Physiology of Somatic Sensation (1) Nephrology and Inflammatory Vascular Diseases (2) Neural Circuits and Behaviour (1) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (1) Pluripotent Stem Cells (1) Proteome Dynamics (4) Proteomics (3) Proteomics and Metabolomics (1) Psychoneuroimmunology (3) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (3) Synaptic Transmission and Plasticity (1) Systems Hematology, Stem Cells & Precision Medicine (1) Translational Bioinformatics (14) Translational Oncology of Solid Tumors (3) Tumor heterogeneity and treatment resistance in pediatric cancer (7) 89 Results: Active Filter: Schmitt, Clemens Prof. Dr.Cancer Genetics and Cellular Stress Responses Sort: Result score Newest to oldest Oldest to newest February 01, 2003 / Curr Opin Dev Chemotherapy response and resistance S. Lee C.A. Schmitt November 01, 2007 / Genes Dev FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf C. Bouchard S. Lee V. Paulus-Hock C. Loddenkemper M. Eilers C.A. Schmitt October 15, 2007 / Blood The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo M. Reimann C. Loddenkemper C. Rudolph I. Schildhauer B. Teichmann H. Stein B. Schlegelberger B. Doerken C.A. Schmitt January 01, 2007 / Biochim. Biophys. Acta Rev. Cancer Cellular senescence and cancer treatment C.A. Schmitt March 15, 2006 / Canc Res Oncogene-induced senescence: putting the brakes on tumor development M. Braig C.A. Schmitt March 16, 2010 / Canc Cell Tumor stroma-derived TGF-beta limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence M. Reimann S. Lee C. Loddenkemper J.R. Dörr V. Tabor P. Aichele H. Stein B. Doerken T. Jenuwein C.A. Schmitt January 01, 2005 / Oncogene Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo A. Helmrich S. Lee P. O'Brien B. Doerken S.W. Lowe E. Schroeck C.A. Schmitt October 04, 2016 / Anal Chem Automated annotation and evaluation of in-source mass spectra in GC/atmospheric pressure chemical ionization-MS-based metabolomics C. Jaeger F. Hoffmann C.A. Schmitt J. Lisec January 01, 2017 / Methods Mol Biol Detecting markers of therapy-induced senescence in cancer cells D.N.Y. Fan C.A. Schmitt July 01, 2017 / Leukemia EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia E. Young D. Noerenberg L. Mansouri V. Ljungström M. Frick L.A. Sutton S.J. Blakemore J. Galan-Sousa K. Plevova P. Baliakas D. Rossi R. Clifford D. Roos-Weil V. Navrkalova B. Dörken C.A. Schmitt K.E. Smedby G. Juliusson B. Giacopelli J.S. Blachly C. Belessi P. Panagiotidis N. Chiorazzi F. Davi A.W. Langerak D. Oscier A. Schuh G. Gaidano P. Ghia W. Xu L. Fan O.A. Bernard F. Nguyen-Khac L. Rassenti J. Li T.J. Kipps K. Stamatopoulos S. Pospisilova T. Zenz C.C. Oakes J.C. Strefford R. Rosenquist F. Damm Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
November 01, 2007 / Genes Dev FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf C. Bouchard S. Lee V. Paulus-Hock C. Loddenkemper M. Eilers C.A. Schmitt
October 15, 2007 / Blood The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo M. Reimann C. Loddenkemper C. Rudolph I. Schildhauer B. Teichmann H. Stein B. Schlegelberger B. Doerken C.A. Schmitt
January 01, 2007 / Biochim. Biophys. Acta Rev. Cancer Cellular senescence and cancer treatment C.A. Schmitt
March 15, 2006 / Canc Res Oncogene-induced senescence: putting the brakes on tumor development M. Braig C.A. Schmitt
March 16, 2010 / Canc Cell Tumor stroma-derived TGF-beta limits Myc-driven lymphomagenesis via Suv39h1-dependent senescence M. Reimann S. Lee C. Loddenkemper J.R. Dörr V. Tabor P. Aichele H. Stein B. Doerken T. Jenuwein C.A. Schmitt
January 01, 2005 / Oncogene Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo A. Helmrich S. Lee P. O'Brien B. Doerken S.W. Lowe E. Schroeck C.A. Schmitt
October 04, 2016 / Anal Chem Automated annotation and evaluation of in-source mass spectra in GC/atmospheric pressure chemical ionization-MS-based metabolomics C. Jaeger F. Hoffmann C.A. Schmitt J. Lisec
January 01, 2017 / Methods Mol Biol Detecting markers of therapy-induced senescence in cancer cells D.N.Y. Fan C.A. Schmitt
July 01, 2017 / Leukemia EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia E. Young D. Noerenberg L. Mansouri V. Ljungström M. Frick L.A. Sutton S.J. Blakemore J. Galan-Sousa K. Plevova P. Baliakas D. Rossi R. Clifford D. Roos-Weil V. Navrkalova B. Dörken C.A. Schmitt K.E. Smedby G. Juliusson B. Giacopelli J.S. Blachly C. Belessi P. Panagiotidis N. Chiorazzi F. Davi A.W. Langerak D. Oscier A. Schuh G. Gaidano P. Ghia W. Xu L. Fan O.A. Bernard F. Nguyen-Khac L. Rassenti J. Li T.J. Kipps K. Stamatopoulos S. Pospisilova T. Zenz C.C. Oakes J.C. Strefford R. Rosenquist F. Damm